NCT07106008View on ClinicalTrials.gov

Radiolabeled TSPO Targeted Molecular Probe in Glioma

Not yet recruitingOBSERVATIONAL

Enrollment

8

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Glioma (Any Grade) in the Brain

All Listed Sponsors

lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT07106008 - Radiolabeled TSPO Targeted Molecular Probe in Glioma | Biotech Hunter | Biotech Hunter